Sometimes You Just Have to Ignore the Economists (with Zephyr Teachout)

Episode Summary

Executive Summary: The episode argues that recent inflation and pandemic-era shortages exposed failures in orthodox economics and justified anti-price-gouging laws. Zephyr Teachout explains that in concentrated markets, emergency disruptions let large firms raise margins rather than spur competition, harming households most when inequality is high. The hosts frame federal action through the FTC or Congress as a needed, practical check on corporate power.

Main Topics: Price gouging as a response to emergency market failures (Priority: 5/5): Teachout argues that during abnormal disruptions like pandemics, storms, and wars, markets do not self-correct quickly enough, so laws limiting non-cost-based price hikes protect consumers from exploitation. Why conventional economics breaks down in concentrated markets (Priority: 5/5): The conversation challenges the Econ 101 idea that higher prices invite quick competition, noting that dominant firms and supply-chain barriers prevent new entrants from disciplining prices in time. Pandemic-era profit margin expansion (Priority: 5/5): The hosts and guest stress that during COVID-19, prices rose alongside profit margins, showing that firms often used shortages to increase profits rather than merely reflect higher costs. Price gouging laws as 'poor man’s antitrust' (Priority: 4/5): Teachout presents state price-gouging statutes as a partial substitute for weak antitrust enforcement, especially when market concentration and inequality already limit fair pricing. Federal versus state enforcement (Priority: 4/5): The discussion emphasizes that state attorneys general can police local retailers, but a national standard and FTC rulemaking would be needed to reach multinational supply chains and close jurisdictional gaps. Political and moral stakes of essential-goods pricing (Priority: 5/5): Examples like insulin and diapers illustrate the human cost of letting ability to pay determine access to necessities, framing price gouging as both an economic and ethical issue. Broader agenda to reduce corporate power (Priority: 3/5): The episode ends by tying price gouging to larger reforms: stronger antitrust enforcement, preventing mergers, and holding large firms to higher labor standards.

Key Arguments: Price gouging laws are not radical price controls; they are common state-level rules that prohibit unjustified emergency markups on vital goods and services. Orthodox economics assumes higher prices trigger rapid entry and lower margins, but that breaks down during temporary shocks and in highly concentrated industries. During COVID-19 and the Ukraine shock, large firms increased both prices and profit margins, proving that price increases were not just cost pass-throughs. Emergency pricing often acts as rationing by wealth, which is especially unjust for necessities like insulin and diapers. State enforcement works for local actors, but a federal rule is necessary because multinational firms can hide markups across complex supply chains. The FTC could use Section 5 and rulemaking to define large, non-cost-based emergency markups as unfair trade practices. A federal law modeled on state statutes would give clearer nationwide rules and force boardrooms to comply during disruptions. Price gouging laws do not solve concentration or inequality, but they are an important partial fix and a practical check on exploitation.

Data Points: Walmart and Amazon pandemic profits: $10 billion increase - Estimated combined profit increase in the first year of the pandemic due to higher margins. Corporate profit margins as share of GDP: 5%-6% to 11%-12% - Used to describe the long-run rise in corporate profit margins under neoliberal policy. Extra corporate share of GDP: About $1.5 trillion - Described as the added amount flowing to profits rather than wages or lower prices. Diaper prices increase: 90% - Mentioned as the first-year pandemic increase in diaper prices. Diaper price increase (alternate discussion estimate): 50% - One speaker notes they may have misremembered and asks for fact-checking, but still emphasizes a very large increase. Emergency price markup allowed in many states: Up to 10% - Typical threshold cited in state price-gouging laws before extra justification is required. Some states' allowed markup: 25% - Alternative higher threshold in a few states before price gouging liability may attach. Some states' allowed markup: 0% - In a few states, any increase during the triggering event can be prohibited unless cost-justified. Insulin production cost: About $2 per vial - Used to show that a $35 cap can still leave substantial profit. Insulin retail price in the U.S. before cap: $400-$500 - Used as an example of extreme domestic pricing before federal action. Insulin price cap: $35 - Referenced as Biden administration action described as a price control. Insulin price in the rest of the world: $8-$10 average - Used to contrast U.S. pricing with other countries.

Pivotal Quotes: "Middle out economics is the answer." — Nick Hanauer: Opening framing of the show's economic philosophy. "After after we failed at market concentration, after we failed at having a free and open market where consumers and workers are fairly and freely negotiating with big corporations, we say, well, at least in radical emergencies around vital and necessary goods, you can't steal from people." — Zephyr Teachout: Summarizing why price gouging laws matter as a fallback protection. "It's more important now than it should be because what we need to do is take it upstream." — Zephyr Teachout: Explaining that price gouging laws are a partial remedy, not a full solution, to corporate power.

Implications: Listeners are urged to see price gouging as a symptom of deeper concentration and inequality. A federal standard could curb emergency exploitation now, while broader antitrust and labor reforms address the root problem.